Murex Named Market Risk Technology Vendor of the Year
Murex, the leading provider of trading, risk management and processing solutions, has been named the Market Risk Technology Vendor of the Year in the 2017 Risk Awards , directed by Risk Magazine. This award gives Murex, MX.3 for Enterprise Risk Management, recognition from the industry for its depth and sophistication of analytics, wide asset class coverage, best-in-breed technology, product innovations, and client support services.
Widely deployed at client sites around the world, MX.3 for Enterprise Risk Management provides a suite of advanced risk modeling, analysis and control tools for credit, market and liquidity risks across all asset classes. The platform uniquely combines sophisticated risk measures and accurate valuation adjustments with unparalleled flexibility. Using high performance computing, and optimization techniques, the solution is engineered to deliver real-time incremental risk metrics at pre or post-trade level manipulating large amounts of data, making it possible to optimize capital performance.
Recent innovations on the platform include MX.3 for FRTB. Launched in February 2016, it delivers a packaged solution for both the Standard and Internal Model Approaches, to help banks meet the Basel committee’s compliance deadline, and rapidly anticipate business impacts. Its high performance Internal Model framework is designed to facilitate regulatory approval, leveraging depth and consistency in trading and risk analytics. The solution covers all asset classes across the full FRTB calculation chain and flexibly adapts to a bank’s existing infrastructure.
Marwan Tabet, Head of Enterprise Risk Management Practice at Murex, comments “With so much focus on risk management in recent years I am delighted that MX.3 has been named the Market Risk Technology Vendor of the year. This award is largely due to our ongoing investment in the platform and commitment to delivering a game changing solution for market risk management. FRTB is the first step toward bringing trading and risk management much closer in the value chain, and banks need to be prepared with the right technology partner in place. Our solution is perfectly positioned for existing users and new clients as we leverage our trading platform and are flexible enough to plug into a bank’s existing architecture as a stand-alone solution. We are already supporting several client’s POCs and FRTB implementation projects with our packaged solution for the IMA and RSA methods.”
Stella Clarke, Chief Marketing Officer at Murex adds “Over the past few months we have been recognized as a leader in our space in the Chartis RiskTech 100, Gartner’s Magic Quadrant for Trading Platforms, Risk Technology Rankings and I am thrilled to be able to add the Risk Awards to our list of accolades. This confirms that our platform strategy, product, and level of service are resonating with end users, analysts and specialists in the field. This is a great achievement, which is shared by everyone who works at Murex.”
About Murex (www.murex.com )
For more than 30 years, Murex has been providing enterprise-wide, cross-asset financial technology solutions to capital markets players. Its cross-function platform, MX.3, supports trading, treasury, risk and post-trade operations, enabling clients to better meet regulatory requirements, manage enterprise-wide risk, and control IT costs. With more than 45,000 daily users in 65 countries, Murex has clients in many sectors, from banking and asset management to energy and commodities.
Murex is an independent company with over 2,000 employees across 17 countries. Murex is committed to providing cutting-edge technology, superior customer service, and unique product innovation.
Nicole Fisher +33144053200
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ASTRAZENECA19.11.2017 00:02 | pressemeddelelse
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases
ASTRAZENECA18.11.2017 19:22 | pressemeddelelse
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer
CHINA-HI-TECH-FAIR18.11.2017 10:13 | pressemeddelelse
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled
NY-MADISON-REALTY17.11.2017 17:22 | pressemeddelelse
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn
NCARDIA17.11.2017 13:33 | pressemeddelelse
Ncardia Announces Completion of €10.5M Investment Round
VOCALINK17.11.2017 10:37 | pressemeddelelse
Double Win for Vocalink at the 2017 Payments Awards
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum